CD4 and mitochondrial DNA depletion syndrome 4a: A new semi‐quantitative POC lateral flow assay, VISITECT CD4 advanced disease test which differentiates CD4 <200 or ≥200 cells/mm3 to rapidly identify AHD, has been WHO prequalified [34].